EQS-Adhoc: LifeWatch AG: LifeWatch now operational in Turkey

   Dow Jones received a payment from EQS/DGAP to publish this press release.

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Interim Report LifeWatch AG: LifeWatch now operational in Turkey

27-March-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR

LifeWatch now operational in Turkey

Zug/Switzerland, March 27, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, is pleased to announce that its Turkish subsidiary, LifeWatch Saglik Hizmetleri A.S., is now fully operational and has started to provide cardiac diagnostic monitoring services to a limited number of Turkish patients. This pre-launch pilot phase lasting three weeks with 60 to 70 volunteer patients in 9 hospitals will allow for a well-controlled entry into the Turkish market and will enable LifeWatch Saglik Hizmetleri to be prepared for a full launch starting mid-April 2017.

LifeWatch's cardiac diagnostic monitoring service is unique in the Turkish healthcare system. Initial feedback from private and public hospitals, payors and government officials has been very encouraging. "This marks a key milestone in LifeWatch's company history. We look forward to serving healthcare providers and patients, helping them to address a significant unmet need across the Turkish population. In turn, we fully expect that LifeWatch Saglik Hizmetleri will significantly contribute to our Group's financial results", said Dr. Stephan Rietiker, CEO of LifeWatch AG.

*For further questions:* LifeWatch AG, Andrew Moore, CFO c/o Communicators AG , Ralph Spillmann Mobile: +41 79 514 64 84 E-Mail: investor-relations@lifewatch.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com [1].

Sign up for customized e-mail alerts and documentation requests at https://www.lifewatch.com/Investor-Relations/Alert-Service.html [2]

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.

Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=VICSERJSCB [3] Document title: LifeWatch now operational in Turkey End of ad hoc announcement Language: English Company: LifeWatch AG Baarerstrasse 139 6300 Zug Switzerland Phone: +41 41 728 67 78 Internet: www.lifewatch.com ISIN: CH0012815459 Valor: 811189 Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt; SIX Swiss Exchange

End of Announcement EQS Group News Service

558191 27-March-2017 CET/CEST

1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=793a282d78899898820d3c7e4bf3c48d&application_id=558191&site_id=vwd&application_name=news 2: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=873f59773724d1b6cd7507597e48246a&application_id=558191&site_id=vwd&application_name=news 3: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=5815b1ef968c2a55d8988cce44e3c186&application_id=558191&site_id=vwd&application_name=news (END) Dow Jones Newswires

   March 27, 2017 01:00 ET (05:00 GMT)- - 01 00 AM EDT 03-27-17